GlassScriptPhysician profile
Kevin Krishna Birusingh
NPI 1497915300
$58,716.92
in general payments reported to CMS, 2019-2025
41 companies · $574 in 2025
The $574 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $194 · 2021: $8,836 · 2022: $45K · 2023: $1,086 · 2024: $1,929 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,997 · Travel and Lodging: $399 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,997.45 |
| Travel and Lodging | $398.51 |
| Education | $193.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $52,850.82 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $877.16 | 2019-2022 | |
| Telix Pharmaceuticals | $848.01 | 2024 | Illuccix |
| Neotract INC. | $504.86 | 2019-2020 | |
| Janssen Biotech, INC. | $494.31 | 2019-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $268.97 | 2023-2025 | Jelmyto |
| Arrow International, INC. | $262.50 | 2022 | |
| Abbvie INC. | $249.21 | 2019-2025 | Botox |
| Astellas Pharma US INC | $217.76 | 2021-2025 | Xtandi, Myrbetriq |
| Dornier Medtech America, INC | $194.95 | 2024 | Dornier Medtech |
| Tolmar Pharmaceuticals, INC. | $184.21 | 2019-2022 | |
| Medtronic, INC. | $160.35 | 2024 | Interstim |
| Intuitive Surgical, INC. | $154.14 | 2019 | |
| Procept Biorobotics Corporation | $148.42 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Pfizer INC. | $128.99 | 2020-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $121.88 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $110.46 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $102.99 | 2024-2025 | Provenge |
| Verity Pharmaceuticals INC. | $77.60 | 2023 | Trelstar |
| Coloplast Corp | $75.15 | 2020-2025 | |
| Olympus America INC. | $73.62 | 2019-2024 | Uretero-Reno Videoscope, Hd Camera Head |
| Axonics, INC. | $62.61 | 2022-2023 | Bulkamid, Axonics |
| Amgen INC. | $46.40 | 2021-2022 | |
| Allergan, INC. | $46.36 | 2019-2021 | |
| Srs Medical Systems, INC. | $45.10 | 2021 | |
| Travere Therapeutics, INC. | $42.81 | 2020-2025 | Thiola |
| E.R. Squibb & Sons, L.L.C. | $35.38 | 2023-2025 | Opdivo |
| Merck Sharp & Dohme LLC | $34.77 | 2025 | Bridion, Keytruda |
| Cook Medical LLC | $33.93 | 2024-2025 | Resonance, S~Curve |
| Endo USA, INC. | $33.19 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $32.77 | 2022-2023 | Xiaflex, Aveed |
| Conmed Corporation | $32.63 | 2024 | Airseal |
| Calyxo, INC. | $25.44 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $21.66 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.19 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.20 | 2025 | Lynparza |
| Myovant Sciences INC. | $16.99 | 2022 | |
| Becton, Dickinson and Company | $16.71 | 2024 | Bard Urinary Drainage Bag |
| C. R. Bard, INC. & Subsidiaries | $15.84 | 2025 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $15.61 | 2025 | Gemtesa |
| Kowa Pharmaceuticals America, INC. | $14.97 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Birusingh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.